Board of Directors
Peter Wyles, President and CEO
Peter joined Ventus Medical as President and CEO in June 2010. He brings to the company broad general management experience in pharmaceuticals, medical devices and consumer health. Prior to joining Ventus Medical, Peter was most recently with Bayer Healthcare for 15 years where he led consumer, pharmaceutical and medical device businesses in Germany, Japan, Canada and the U.S. More recently, he led the global expansion and integration of Metrika, a former start-up in the diabetes space that was acquired by Bayer HealthCare in 2006. Peter is a graduate of Thunderbird School of Global Management, where he earned his MBA in and Pennsylvania State University, where he earned his BA. He served in the United States Marine Corps where he had assignments Moscow, Russia, Pretoria, South Africa and Tegucigalpa, Honduras.
Rajiv Doshi, MD, Founder, Ventus Medical
Rajiv invented the core technology and founded Ventus Medical. Rajiv is a Consulting Assistant Professor of Medicine and a Lecturer of Mechanical Engineering at Stanford University. Rajiv also serves as the Executive Director (US) of Stanford-India Biodesign, a Government of India supported program to promote medical technology industry growth in India. Previously, Rajiv was a Principal at De Novo Ventures. He is the inventor on over 30 pending and issued patents. Rajiv serves on the Medical Advisory Board of Lunar Design and serves as an advisor to multiple early stage medical technology companies in the United States and India. Rajiv earned a BS in Chemical Engineering, an MSE in Biomechanical Engineering and an MD from Stanford University.
Josh Green, Partner, Mohr Davidow Ventures
Josh Green joined MDV's investing team in 2006. Josh applies his experience in a broad range of industries including cleantech and medical devices to help entrepreneurs define their markets and products. Josh has more than 25 years of experience working with companies from startup phase to large public company, and has helped many management teams focus their energy on building value for the enterprise and its stakeholders. Throughout his career he has guided entrepreneurs and helped to build some of the most successful emerging growth companies in Silicon Valley including the Internet (Yahoo!), biotechnology (Geron), medical devices (Target Therapeutics), telecommunication/networking (Cerent) and semiconductors (Xilinx). Josh graduated magna cum laude from UCLA in 1977 and the UCLA School of Law in 1980 where he was on the Law Review.
Kevin J. Appelbaum, President & CEO, Tria Beauty, Inc.
Kevin has spent 20+ years working with, and leading companies in every stage of development as both an operating executive and strategic advisor. Since 2001, he has focused his efforts in the healthcare and consumer industries. He has a unique blend of traditional healthcare experience and commercial know-how, selling directly to consumers and building global brands. Prior to joining TRIA, Kevin was an executive with Sephora, and gained operating and business leadership experience with Procter & Gamble, PepsiCo and as CEO of the venture capital backed e-retailer Tavolo, Inc. Kevin received his bachelor's degree in Chemical Engineering from the University of Pennsylvania and began his career as an Army infantry officer, commanding several Ranger platoons and serving in the US and abroad. Kevin is on the Board of Directors of TRIA Beauty, Inc. and Ventus Medical, Inc., and member of Young Presidents Organization.
David Mauney, MD, Managing Director, De Novo Ventures
David is a co-founder and Managing Director of De Novo Ventures. Previously, he was a Partner at Asset Management Company, where he worked with Pitch Johnson in healthcare investments. At Asset Management, he led seed and early stage investments in TriVascular (acquired by Boston Scientific), Novare Surgical Systems (licensed to Johnson & Johnson), and Enteric Medical Technologies (acquired by Boston Scientific). David was the first Director of Business Development for FoxHollow Technologies (Nasdaq: EVVV). He earned his MD degree from The Dartmouth School of Medicine and a BA from Duke University.
Jay Watkins, Managing Director, De Novo Ventures
Jay is a Managing Director at De Novo Ventures. Previously, Jay was a co-founder of Origin Medsystems, a venture-funded medical technology start-up that was purchased by Eli Lilly & Company in 1992. He then served on the management committee of Guidant Corporation from 1995-2002. Additionally, Jay was the President of Compass, Guidant Corporation’s corporate business development and new ventures group. He has been on the board of several public companies, including Gynecare, Cardiogenesis, and Rita Medical. Jay received his MBA from Harvard University and his undergraduate degree from Stanford University.
Niamh Pellegrini, Vice President, Venture Investments, JJDC
Niamh joined Johnson & Johnson Development Corporation (JJDC) in 2009. She is based in Silicon Valley, California. Ms. Pellegrini has more than twenty years of operational experience at Johnson & Johnson in a variety of cross functional roles including sales, marketing, information technology and finance. Most of her career has been focused on diagnostic solutions for diabetes at LifeScan where Ms. Pellegrini led strategic planning, portfolio management, and the commercial execution of Lifescan’s US $1B+ consumer blood glucose monitoring business. Most recently, she was responsible for managing LifeScan’s inpatient hospital businesses. Ms. Pellegrini received a Bachelor of Science in Finance and a Masters of Business Administration from Santa Clara University.